Table 2: Summary of results of meta-analysis to identify sex differences among the included studies
OutcomeNo. of studiesSubjects, nPooled OR or SMD
 (95% CI)I2, %Summary of sex differencesGRADE quality of evidence
MF
Illicit opioid use
Cohort studies24,30,433 9768140.81 (0.50 to 1.31)82-Very low*†
RCTs32,40*403‡75381.39 (0.61 to 3.19)0-Moderate§
Treatment retention27,30,35310105851.01 (0.62 to 1.63)77-Low
Polysubstance use
Alcohol use24,30,393 8097010.52 (0.31 to 0.86)77Women less likely to use alcoholModerate*¶
Amphetamine use35,38226914621.47 (1.12 to 1.94)0Women more likely to use amphetaminesLow
Benzodiazepine use35,38226914620.94 (0.70 to 1.27)44-Low
Cannabis use35,38226914620.85 (0.67 to 1.08)0-Low
Cocaine use35,38,39328265711.07 (0.64 to 1.78)76-Very low*†§¶
Other
Methadone dosage (maintenance)26,352 562234-2.38 (5.67 to 0.91)0-Low
Legal involvement24,302 6745920.63 (0.47 to 0.84)39Women less likely to report arrests or legal supervisionModerate*†¶
Employment during treatment24,25,28,30,395129110300.39 (0.21 to 0.73)91Women less likely to be employedModerate*§¶**
Marital status24,25,30,39411008780.96 (0.75 to 1.21)0-Low
Death27,432 5813531.61 (0.60 to 4.33)83-Low

Note: CI = confidence interval, GRADE = Grading of Recommendations Assessment, Development and Evaluation,23, OR = odds ratio, RCT = randomized controlled trial, SMD = standardized mean difference.
*Differences in outcome definition and measurement among studies.
†Studies did not adjust for relevant treatment-related confounders (e.g., methadone dosage, opioid use, other medications).
‡This meta-analysis included 2 studies, but 1 study (Schottenfeld et al.,40) had 2 methadone intervention arms (65 mg and 20 mg), which were both included separately.
§Small samples and wide confidence intervals across studies.
¶Significant association at p < 0.01.
**Inadequate statistical measures and some missing data.